Newbridge Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-300
Closed -$4.37K 1269
2025
Q3
$4.37K Sell
300
-529
-64% -$6.33K ﹤0.01% 1044
2025
Q2
$9.32K Buy
829
+529
+176% +$4.1K ﹤0.01% 909
2025
Q1
$1.71K Hold
300
﹤0.01% 905
2024
Q4
$2.95K Hold
300
﹤0.01% 929
2024
Q3
$2.44K Hold
300
﹤0.01% 547
2024
Q2
$4.01K Sell
300
-50
-14% -$1.49K ﹤0.01% 878
2024
Q1
$16.2K Buy
350
+300
+600% +$15.5K 0.01% 648
2023
Q4
$3.38K Hold
50
﹤0.01% 908
2023
Q3
$3.62K Sell
50
-175
-78% -$14K ﹤0.01% 1000
2023
Q2
$16.7K Sell
225
-25
-10% -$1.48K 0.01% 746
2023
Q1
$13.3K Buy
250
+225
+900% +$14.3K 0.01% 850
2022
Q4
$1.69K Hold
25
﹤0.01% 1244
2022
Q3
$3K Hold
25
﹤0.01% 1124
2022
Q2
$2K Sell
25
-69
-73% -$8.42K ﹤0.01% 1168
2022
Q1
$15K Buy
94
+69
+276% +$13.4K 0.01% 804
2021
Q4
$8K Sell
25
-13
-34% -$6.17K ﹤0.01% 964
2021
Q3
$17K Buy
+38
New +$18.5K 0.01% 710

Other funds holding DNA